Beranda › Kanker Prostat Resisten Kastrasi › New Jersey
Uji klinis Kanker Prostat Resisten Kastrasi di New Jersey
4 studi untuk Kanker Prostat Resisten Kastrasi mencari peserta di lokasi di New Jersey.
Teks studi resmi (Bahasa Inggris)
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Astera Cancer Care, East Brunswick
- Rutgers Cancer Institute of New Jersey, New Brunswick
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07225946A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START New Jersey, East Brunswick
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 24 Sep 2026 · NCT07719361A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan
- Novartis, East Hanover
Menerima pesertaStudi observasional
Usia 18 hingga 115 · Pria · Diperbarui 16 Jul 2026 · NCT07677267A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer
- Novartis, East Hanover
Menerima pesertaStudi observasional
Usia 18 hingga 115 · Pria · Diperbarui 16 Jul 2026 · NCT07677254Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.